Skip to main content

Sorenson John Bradley's Form 4 filing

Boston Scientific CorpBSX · filed Feb 19, 2025

Accession no.
0001225208-25-001971
Filed
Feb 19, 2025
Trade date
Feb 18-19, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions. Open-market sales total $624.9K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sorenson John BradleyCIK 0001629277Officer (EVP, Global Operations)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 18, 2025Common StockSSaleDisposed−2,657$104.41−$277,417.3724,294Direct
Feb 19, 2025Common StockSSaleDisposed−3,303$105.19F2−$347,442.5720,991Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $105.02 to $105.365, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)